Gout and Rheumatoid Arthritis: Available Options for Pharmacotherapy. Overview of World Data
Abstract
Due to adverse effects, old-age uricosuric medications have been withdrawn only to assisted treatment of gout. Their place was taken by Xanthine Oxidase (XOI) inhibitors as the first-choice medication. Although they are easier to monitor and free from many side effects, they have a limited spectrum of associations. New-generation uricosuric medications have been included in combination therapy with XOI. They can also be used alone in the case of patients with XOI
Article Information
| Journal | SF Journal of Clinical Pharmacology and Research |
| Article Type | Review Article |
| Volume | 2 |
| Issue | 1 |